Cargando…

Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single‐cell RNA sequencing

BACKGROUND: Gallbladder cancer (GC) is a malignant disease characterized with highly cellular heterogeneity and poor prognosis. Determining the intratumoral heterogeneity and microenvironment (TME) can provide novel therapeutic strategies for GC. METHODS: We performed the single‐cell RNA sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peizhan, Wang, Yueqi, Li, Jingquan, Bo, Xiaobo, Wang, Jie, Nan, Lingxi, Wang, Changcheng, Ba, Qian, Liu, Houbao, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236117/ https://www.ncbi.nlm.nih.gov/pubmed/34185421 http://dx.doi.org/10.1002/ctm2.462

Ejemplares similares

ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer
por: Nan, Lingxi, et al.
Publicado: (2022)

High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer
por: Bo, Xiaobo, et al.
Publicado: (2020)

Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
por: Wang, Jie, et al.
Publicado: (2019)

Cystic Duct Carcinoma: A New Classification System and the Clinicopathological Features of 62 Patients
por: Nan, Lingxi, et al.
Publicado: (2021)

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
por: Bo, Xiaobo, et al.
Publicado: (2017)

Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment
por: Zhang, Yigang, et al.
Publicado: (2021)

Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010‐2016
por: Wang, Jie, et al.
Publicado: (2019)

High expression of PALB2 predicts poor prognosis in patients with advanced breast cancer
por: Li, Jingquan, et al.
Publicado: (2017)

Single‐cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer
por: Yu, Zhicheng, et al.
Publicado: (2022)

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
por: Jia, Qingzhu, et al.
Publicado: (2018)

Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2020)

Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion
por: Zhang, Bao, et al.
Publicado: (2023)

Unsupervised Deconvolution of Dynamic Imaging Reveals Intratumor Vascular Heterogeneity and Repopulation Dynamics
por: Chen, Li, et al.
Publicado: (2014)

Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis
por: Wang, Jiwen, et al.
Publicado: (2017)

Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
por: Zhang, Wenhui, et al.
Publicado: (2021)

Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution
por: Su, Narun, et al.
Publicado: (2022)

Metabolomics reveals intratumor heterogeneity – Implications for precision medicine
por: Liu, Xiaojing, et al.
Publicado: (2017)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
por: Zhou, Yan, et al.
Publicado: (2021)

The significance of intertumor and intratumor heterogeneity in liver cancer
por: Liu, Jinping, et al.
Publicado: (2018)

Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway
por: Shen, Sheng, et al.
Publicado: (2016)

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
por: Zhou, Huaqiang, et al.
Publicado: (2021)

Polysome Profiling of a Human Glioblastoma Reveals Intratumoral Heterogeneity
por: Lupinacci, Fernanda Cristina Sulla, et al.
Publicado: (2019)

Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
por: Liu, S. John, et al.
Publicado: (2020)

Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Intratumoral Heterogeneity in Lung Cancer
por: Lv, Xiaodi, et al.
Publicado: (2023)

Bioavailable 25(OH)D but Not Total 25(OH)D Is an Independent Determinant for Bone Mineral Density in Chinese Postmenopausal Women
por: Li, Chenguang, et al.
Publicado: (2016)

Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity
por: Kim, Jihyun, et al.
Publicado: (2022)

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
por: Juratli, Tareq A., et al.
Publicado: (2017)

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
por: Romero, Irene, et al.
Publicado: (2018)

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
por: Mota, Alba, et al.
Publicado: (2022)

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
por: Su, Guan-Hua, et al.
Publicado: (2023)

Intratumor Epigenetic Heterogeneity—A Panel Gene Methylation Study in Thyroid Cancer
por: Zhu, Chaofan, et al.
Publicado: (2021)

TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
por: Yuedi, Dai, et al.
Publicado: (2017)

Unifying models of glioblastoma’s intratumoral heterogeneity
por: Lam, K H Brian, et al.
Publicado: (2020)

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_plnqdotldi62go4i39pcnc24ot